---
figid: PMC7445419__er.2018-00141f1
figlink: pmc/articles/PMC7445419/figure/fig1/
number: Figure 1
caption: '(a) Insulin signal transduction system in individuals with normal glucose
  tolerance (see text for a detailed discussion). NOS, nitric oxide synthase. (b)
  In individuals with T2DM, insulin signaling is impaired at the level of IRS-1, leading
  to decreased glucose transport/phosphorylation/metabolism and impaired nitric oxide
  synthase activation/endothelial dysfunction. At the same time, insulin signaling
  through the MAPK pathway remains normally sensitive to insulin. The compensatory
  hyperinsulinemia (due to insulin resistance in the IRS-1/PI3K pathway) results in
  excessive stimulation of the MAPK pathway, which is involved in inflammation, vascular
  smooth muscle cell proliferation, and atherogenesis (see text for a more detailed
  discussion). SHC, Src homology collagen. [DeFronzo RA: From the triumvirate to the
  ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes
  58:773–795, 2009. American Diabetes Association, Diabetes, 2009. Copyright and all
  rights reserved. Material from this publication has been used with the permission
  of the American Diabetes Association.]'
pmcid: PMC7445419
papertitle: 'Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing
  Agents.'
reftext: Antonino Di Pino, et al. Endocr Rev. 2019 Dec;40(6):1447-1467.
pmc_ranked_result_index: '69905'
pathway_score: 0.9662194
filename: er.2018-00141f1.jpg
figtitle: ' Insulin signal transduction system in individuals with normal glucose
  tolerance (see text for a detailed discussion)'
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7445419__er.2018-00141f1.html
  '@type': Dataset
  description: '(a) Insulin signal transduction system in individuals with normal
    glucose tolerance (see text for a detailed discussion). NOS, nitric oxide synthase.
    (b) In individuals with T2DM, insulin signaling is impaired at the level of IRS-1,
    leading to decreased glucose transport/phosphorylation/metabolism and impaired
    nitric oxide synthase activation/endothelial dysfunction. At the same time, insulin
    signaling through the MAPK pathway remains normally sensitive to insulin. The
    compensatory hyperinsulinemia (due to insulin resistance in the IRS-1/PI3K pathway)
    results in excessive stimulation of the MAPK pathway, which is involved in inflammation,
    vascular smooth muscle cell proliferation, and atherogenesis (see text for a more
    detailed discussion). SHC, Src homology collagen. [DeFronzo RA: From the triumvirate
    to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.
    Diabetes 58:773–795, 2009. American Diabetes Association, Diabetes, 2009. Copyright
    and all rights reserved. Material from this publication has been used with the
    permission of the American Diabetes Association.]'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC2A4
  - SART3
  - IRS1
  - AKT2
  - AKT3
  - AKT1
  - PI3
  - NOS1
  - NOS2
  - NOS3
  - SHC1
  - SHC3
  - SHC4
  - SHC2
genes:
- word: GLUT4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: IRS-1)
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3
  symbol: PI3
  source: hgnc_symbol
  hgnc_symbol: PI3
  entrez: '5266'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS1
  entrez: '4842'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS2
  entrez: '4843'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: GLUT4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3
  symbol: PI3
  source: hgnc_symbol
  hgnc_symbol: PI3
  entrez: '5266'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
chemicals: []
diseases: []
---
